Peter Conti and Johan Spoor agreed to resign as directors of FluoroPharma Medical Inc., effective Jan. 1, 2017.
The resignations are not due to any disagreements on any matter relating to the company's operations, policies and practices.
Discover more about S&P Global’s offerings